myNEO
Gent, Belgium
myNEO Therapeutics leads in Personalized Medicine and genomic-informed drug discovery in the key therapeutic areas of oncology and immunology. The myNEO ImmunoEngine© is a sequencing-based computational neoepitope selection platform that predicts the most efficacious targets for each individual cancer patient, key to developing a successful personalized immunotherapy. In parallel, the DataScovery© platform continuously screens public and privately gathered databases to discover new immunogenic targets for both untackled cancer indications and new infectious diseases. To coninously increase clinical performance of the platform, data of all patients across biopharma partners are combined into one centralized myNEO network.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- www.myneotx.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of myNEO?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now